期刊文献+

骨原发性恶性淋巴瘤临床病理及P53蛋白表达的研究 被引量:1

The Clinicopathology and P53 Protein Expressin Study of Primary Lymphoma of Bone
下载PDF
导出
摘要 目的 :复习文献对 7例骨原发性恶性淋巴瘤 (PrimaryLymphomaofBone ,PLB)进行临床病理分析 ,并检测其P5 3的表达情况。方法 :对瘤组织采用常规石蜡切片、HE染色及ABC法免疫组化染色 ,光镜观察。结果 :患者年龄 16~ 68岁 ,平均 3 7岁 ,以男性多见 ( 6 7例 ) ,好发于扁骨 (骼骨 2例 ,胸骨 1例 ,3 7例 )。多数为B细胞性淋巴瘤 ( 5 7例 ) ,T细胞性淋巴瘤 ( 1 7例 )和组织细胞性淋巴瘤少见 ( 1 7例 )。 7例PLB中 3例 ( 4 2 .8% )表达P5 3阳性 ,2 1例慢性骨髓炎对照组中仅 1( 5 % )例表达P5 3弱阳性 ,两组间有显著差异 (P <0 .0 5 )。结论 :PLB以B细胞性多见 。 Objective:To review the concerned literature and to investigate the characteristics of clinicopathology,and to detect P53 protein expression for Primary Lymphoma of Bone(PLB) in 7 cases.Methods:The routine paraffin slides were cut,stained with H.E and immunochemically stained with ABC method,and then,observed under optical microscopy.Results:The average age of the 7 patients was 37.The tumor were prevalent in men(6/7 cases)and mainly occurred in flat bone(2 cases in ilium,1 case in sternum).The tumors were predominate B cell lymphoma (5/7 cases)and less common in T cell(1/7 cases)and histiocyte lymphoma(1/7 cases).On the immunochemically stained slides,the tumor cells of 3 cases(42.8%) expressed P53 positive.In 21 cases of chronic osteomyelitis control group,only 1 case(5%) expressed P53 weak positive.There was significant difference between the two groups( P <0.05).Conclusions:Most of PLB was B cell Lymphoma and its origination might be associated with malignant change of B lymphocytes in bone marrow.The P53 protein expressed abnormally in PLB. \ \
出处 《镇江医学院学报》 2000年第1期21-23,共3页 Journal of Zhenjiang Medical College
关键词 骨原发性 恶性淋巴瘤 P53蛋白表达 免疫组化 Bone lymphoma Clinicopathology Immunohistiochemistry gene P53
  • 相关文献

参考文献1

  • 1武文森,尹克铮,谢钰勤.11例骨原发性非何杰金氏淋巴瘤临床病理分析[J]临床与实验病理学杂志,1990(01).

同被引文献15

  • 1周志韶,喻毅强,黄志勇,蒋巧生,张慰泽,徐天蓉,孙毅,龚嘉仪,蔡德巍,徐千里,李涤臣.脾原发性非何杰金淋巴瘤[J].临床与实验病理学杂志,1995,11(2):95-98. 被引量:6
  • 2Jaffe ES, Nancy LH, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].IARC Press: Lyon, 2001.109-234.
  • 3Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization Classification of neoplastic diseases of the naematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting[J]. Histopathology, 2000, 36: 69-87.
  • 4Skarin AT, Taylor CR, Long JC. Lymphosarcoma of the spleen[J]. Arch Intern Med, 1991, 127: 259.
  • 5Keho EJ, Straus DJ. Primary lymphoma of the spleen: clinical feature sand out come after splenectomy [J]. Cancer, 1988, 62(10): 1433-1438.
  • 6Petti B, Dosoretz DE, Pileri SA, et al. Primary Lymphoma of the temporal spleen[J]. Am J Surg Pathol, 1990, 14:652-659.
  • 7Swerdlow SH. Small B-cell lymphomas of the node and spleen: practtical insights to diagnosis and pathogenesis[J]. Mod Pathol, 1999, 12: 125-140.
  • 8Radaszkicz T, Tucci DL. A morphologic and immunohistochemical analysis of Primary Lymphoma of spleen[J]. Virchows Arch, 1988, 413:269-174.
  • 9Young AN, Ehya H, Klein SA, et al. Differentiating large cell lymphoma from indolent small B-cell lymphoma in fine needle aspirates using p53, PCNA and transformed lymphocyte count[J]. Acta Cytol, 2000, 44(4): 592.
  • 10Petit B, Leroy K, Kanavaros P, et al. Expression of p53 proteinin T and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations[J]. Hum Pathol, 2001, 32(2): 196.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部